Earnings Call Transcripts
Access detailed transcripts and key takeaways from company earnings calls
All Earnings Calls
InnovAge FY2026 Q3 Earnings Call - Raised Full-Year Guidance on Margin Expansion and AI-Driven Efficiency
InnovAge delivered a solid third quarter of fiscal 2026, driven by better-than-expected Medicaid rates, favorable Medicare risk scores, and disciplined medical management. The company raised its full-...
- InnovAge reported Q3 FY2026 revenue of $251.9 million, up 15.5% year-over-year, driven by higher capitation rates and 6.9% census growth.
- Center-level contribution margin expanded to $61 million (24.2% of revenue), a significant improvement from $40.7 million in Q3 FY2025.
- Adjusted EBITDA rose to $30.5 million, up from $10.8 million in the prior year quarter, supporting an updated full-year EBITDA guidance range of $85 million to $90 million.
- +7 more takeaways
Amwell Q1 2026 Earnings Call - Payer Margin Pressure Fuels Platform Consolidation Play
Amwell reported Q1 2026 results that underscore a deliberate pivot from legacy urgent-care volumes to a unified, payer-facing platform. Total revenue fell 18% year-over-year to $54.9 million, dragged ...
- Total revenue fell 18% year-over-year to $54.9 million, driven by subscription churn, but Amwell Medical Group visit revenue rose 9% to $28.9 million as higher-acuity care gained share.
- Subscription revenue declined 23% to $24.9 million, yet renewals and retention exceeded budget, signaling improving base stability despite prior churn.
- Amwell Medical Group executed roughly 382,000 paid visits, with revenue per visit climbing to $76, up $5 year-over-year, reflecting a favorable shift in visit mix.
- +7 more takeaways
Ouster Q1 2026 Earnings Call - Native Color LiDAR Revolutionizes Physical AI Perception
Ouster delivered a record $49 million in Q1 2026 revenue, driven by a 49% year-over-year increase and the early contributions from its StereoLabs acquisition. The quarter marked a strategic inflection...
- Q1 2026 revenue reached $49 million, a 49% year-over-year increase, marking the 13th consecutive quarter of product revenue growth.
- The company shipped over 12,600 sensors, including a record 8,300 LiDAR units and 4,300 camera sensors.
- GAAP gross margin improved to 43%, up 200 basis points year-over-year, despite supply chain constraints.
- +9 more takeaways
Mercury Systems Q3 FY2026 Earnings Call - Record Backlog and Margin Expansion Drive Raised Outlook
Mercury Systems delivered a strong Q3 FY2026 performance, exceeding expectations with record bookings of $348.3 million and a book-to-bill ratio of 1.48. This drove a record backlog approaching $1.6 b...
- Record bookings of $348.3 million in Q3 FY2026, resulting in a 1.48 book-to-bill ratio and a record backlog approaching $1.6 billion, up 18% year-over-year.
- Revenue grew 11.5% organically to $235.8 million, with domestic revenue up 17% year-over-year, representing 88% of total sales.
- Adjusted EBITDA surged 46% to $36.1 million, with margins expanding 360 basis points year-over-year to 15.3%, exceeding expectations.
- +7 more takeaways
The Hackett Group Q1 2026 Earnings Call - Margin Inflection Expected in Q3 as AI Platform Transition Accelerates
The Hackett Group reported Q1 2026 revenues before reimbursements of $68.7 million, down 11% year-over-year, with adjusted EPS of $0.34 at the low end of guidance. The company is executing a strategic...
- Q1 2026 revenues before reimbursements were $68.7 million, an 11% decline year-over-year, reflecting macro headwinds and elongated client decision cycles.
- Adjusted EPS came in at $0.34, at the low end of guidance, as the company absorbs costs from its strategic AI transition.
- The firm is aggressively migrating from labor-based services to an AI platform-enabled delivery model using proprietary tools like Hackett AI XPLR and the ZBrain agentic orchestration platform from LeewayHertz.
- +11 more takeaways
Cricut Q1 2026 Earnings Call - Platform Revenue Growth Masks Product Revenue Decline
Cricut reported a 2% year-over-year revenue decline to $159.5 million in Q1 2026, driven by a 9.6% drop in product revenue as the company shifted to lower-priced, bundle-only machines. However, platfo...
- Total revenue declined 2% year-over-year to $159.5 million, with product revenue falling 9.6% due to lower average selling prices and promotional activity.
- Platform revenue grew nearly 6% year-over-year to $84.8 million, driven by a 3% increase in paid subscribers to 3.08 million and a 4.8% rise in ARPU.
- Global machine sell-out units increased year-over-year, signaling strong consumer demand for new bundle-only offerings like the Joy 2 and Explore 5.
- +10 more takeaways
TransMedics Q1 2026 Earnings Call - Revenue Growth Hits 21% as CHOPS and Gen 3.0 Drive Strategic Expansion
TransMedics delivered a solid Q1 2026 with total revenue of $174 million, up 21% year-over-year, driven by strong liver performance and growing OCS case volumes. The company is aggressively investing ...
- Total revenue for Q1 2026 reached $174 million, representing 21% year-over-year growth and 8% sequential growth, led by strong liver performance and increased OCS case volumes.
- U.S. transplant product revenue grew 22% year-over-year to $102 million, while international revenue surged 39% year-over-year to $6 million, driven by heart and lung adoption.
- Adjusted operating profit of $18.1 million reflected a 10.4% operating margin, down from prior periods due to strategic investments in R&D and international expansion.
- +7 more takeaways
Revolve Group Q1 2026 Earnings Call - Accelerating Growth and Strategic Investments Drive Market Share Gains
Revolve Group delivered a strong first quarter in 2026, with net sales rising 16% year-over-year to $343 million, marking its fastest growth rate in nearly four years. The company's strategic investme...
- Net sales increased 16% year-over-year to $343 million, the highest growth rate in nearly four years, with a 5-point sequential improvement from Q4 2025.
- Diluted earnings per share rose 25% year-over-year to $0.20, reflecting strong bottom-line performance despite increased marketing investments.
- International net sales grew 20% year-over-year, marking the 13th consecutive quarter of international growth outpacing the U.S., despite a slowdown in the Middle East.
- +7 more takeaways
DaVita Q1 2026 Earnings Call - Raised Guidance on Volume Surge and Fresenius Transfers
DaVita delivered a sharp first quarter, beating expectations on revenue per treatment and cost discipline while quietly capturing market share from Fresenius clinic closures. The company lifted full-y...
- Full-year adjusted operating income guidance raised to $2.15B-$2.25B, up $40M midpoint, driven by volume and labor efficiency.
- Full-year adjusted EPS guidance lifted to $14.10-$15.20, reflecting higher volume and lower patient care costs.
- Treatment volume guidance increased from flat to +25-50 basis points, with roughly half attributed to Fresenius clinic transfers.
- +9 more takeaways
American Coastal Insurance Corporation Q1 2026 Earnings Call - Discipline Wins as Soft Market Pressures Rates But Margins Hold
American Coastal Insurance (ACIC) reported Q1 2026 net income of $19.3 million, driven by a 66% combined ratio that reflects sharp underwriting discipline in a rapidly softening commercial property ma...
- Q1 2026 net income came in at $19.3 million, with core income also at $19.3 million, down $1.4 million year-over-year as net premium earned declined, though this was partially offset by lower total expenses.
- The combined ratio stood at 66%, just 1 point higher than the prior year, while the non-GAAP underlying combined ratio was 68.3%, demonstrating stable underwriting margins despite a softening commercial property market.
- CEO Bennett Bradford Martz confirmed average account rate decreases are distorting premium growth, but policy counts and exposure bases actually increased year-over-year, signaling strong account retention and market leadership defense.
- +7 more takeaways